packageAlipogeneTiparvovec

alipogene tiparvovec

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alipogene tiparvovec (Glybera) is a gene therapy that was used to treat a rare inherited disorder causing very high blood fat levels, known as type I hyperlipoproteinemia.

Summary written by glm-5.3-flash from Wikidata Q5572516 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:alipogene tiparvovec
ATC codes:C10AX10
DrugBank:DB13521
Wikidata:Q5572516

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown